New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 27, 2010
14:19 EDTHSP, MCK, ABC, SNYRumor: Pharma Distributors move up on speculation of a positive court ruling
Shares of Hospira (HSP), McKesson (MCK) and AmerisourceBergen (ABC) are moving higher on conjecture that a District Court declared Sanofi's patents invalid, clearing the way for generic Taxotere.
News For HSP;MCK;ABC;SNY From The Last 14 Days
Check below for free stories on HSP;MCK;ABC;SNY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
07:03 EDTABCAmerisourceBergen now sees FY14 adjusted continuing ops EPS $3.89-$3.94
Consensus is $3.73. Sees FY14 revenue growth in the 35% range, consensus $116.72B. The company says "Adjusted operating margin is expected to decline in the high-teens basis points range due to the onboarding of significant new lower margin business and growth in brand pharmaceutical business with our large customers. We expect free cash flow to be in the high end of the range of $500 to $700 million, with capital expenditures in the $275 million range, and to spend approximately $500 million in share repurchases, subject to market conditions."
07:02 EDTABCAmerisourceBergen reports Q3 continuing ops EPS $1.01, consensus 92c
Reports Q3 revenue $30.35B, consensus $29.25B.
July 23, 2014
10:02 EDTHSPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:10 EDTHSPDeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
July 22, 2014
16:08 EDTHSPHospira initiated with a Hold at Deutsche Bank
Target $53.
July 21, 2014
07:11 EDTSNYInternational Society of DNA Vaccines to hold a conference
Subscribe for More Information
July 18, 2014
10:48 EDTHSPHigh option volume stocks
Subscribe for More Information
July 16, 2014
09:03 EDTSNYSanofi held talks on mature drugs with Abbott, Mylan, PE firms, Reuters says
Sanofi (SNY) has shopped an $8.5B portfolio of mature drugs to Abbott (ABT), Mylan (MYL) and private equity firms, according to Reuters, citing an internal company document circulated by the CGT union. Sanofi is considering whether to sell, carve out or create a joint venture for the portfolio of about 200 drugs, but a Sanofi spokesman said no decision has yet been made, the report noted. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use